endocrine therapy resistance in er metastatic breast cancer
Published 3 years ago • 562 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:27
treating er breast cancer patients with endocrine therapy resistance
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
1:00
emerging mechanisms of resistance to endocrine therapies in hr breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
1:00
therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancer
-
1:11
endocrine therapy treatment radiosensitizes er breast cancer
-
1:56
vepdegestrant palbociclib in er metastatic breast cancer: phase ib trial results
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
4:22
how to use endocrine therapy in premenopausal women with er metastatic breast cancer
-
3:15
investigating targeted therapy combinations in metastatic hr breast cancer
-
1:19:57
overcoming endocrine resistance in er-positive metastatic breast cancer
-
9:02
endocrine resistance in hr metastatic breast cancer
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
1:52
dr. ellis on resistance to endocrine therapy in hr metastatic breast cancer
-
0:35
duration of endocrine therapy in early breast cancer